+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated Molecular Diagnostics Testing System Market - Global Forecast 2026-2032- Product Image
Automated Molecular Diagnostics Testing System Market - Global Forecast 2026-2032- Product Image
Sale

Automated Molecular Diagnostics Testing System Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6280362
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introduction to Automated Molecular Diagnostics Testing Systems

Automated molecular diagnostics testing systems integrate specimen preparation, nucleic-acid extraction, amplification, detection, interpretation, and result reporting with limited manual intervention. Their value is linked to faster and more consistent workflows, reduced hands-on requirements, and improved suitability for laboratories managing infectious-disease, oncology, genetic, and other molecular assays. Adoption depends on clinical utility, regulatory authorization, laboratory capacity, reimbursement, procurement priorities, and interoperability with information systems.

Transformative Shifts Reshaping Molecular Diagnostics Workflows

The landscape is shifting from fragmented, labor-intensive processes toward integrated and increasingly decentralized testing workflows. Laboratories are prioritizing standardized consumables, closed or semi-closed systems, shorter turnaround times, contamination control, and connectivity with laboratory and hospital information systems. Multiplex testing, syndromic panels, near-patient deployment, and flexible throughput are also influencing platform selection, while supply-chain resilience and cybersecurity have become important operational considerations.

How Artificial Intelligence Is Changing Automated Molecular Testing

Artificial intelligence is contributing to automated molecular diagnostics through quality-control monitoring, signal interpretation, anomaly detection, workflow optimization, and predictive maintenance. AI can support result triage and integrate molecular findings with clinical or epidemiological information, but dependable deployment requires representative validation data, transparent performance evaluation, human oversight, and compliance with privacy and medical-device requirements. The most practical near-term applications are decision support and operational efficiency rather than unsupervised diagnosis.

Regional Insights Across Global Testing Environments

North America generally emphasizes high-throughput laboratory networks, interoperability, regulatory compliance, and decentralized access for underserved settings. Europe places strong weight on harmonized regulation, data governance, laboratory quality, and cross-border health coordination. Asia-Pacific combines advanced systems in Japan, South Korea, Australia, and other mature markets with rapidly expanding diagnostic capacity across populous and diverse health systems. Latin America is shaped by public-sector procurement, referral-laboratory networks, import dependence, and unequal access. The Middle East is investing in centralized and specialized healthcare infrastructure, while the GCC places particular emphasis on modern laboratory capacity. Africa’s priorities include affordable decentralized testing, disease-surveillance capability, workforce development, and robust operation in settings with variable infrastructure.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members face varied regulatory systems and healthcare capacities, making portability, local service support, and scalable workflows important. BRICS economies combine significant diagnostic needs with differing procurement models, domestic-manufacturing objectives, and access conditions. The European Union prioritizes regulatory conformity, laboratory quality, data protection, and coordinated health security. G7 countries tend to focus on advanced automation, evidence generation, resilience, and integration with established healthcare infrastructure. GCC states emphasize centralized modernization, specialist services, and workforce capability. NATO countries also view diagnostic readiness, continuity of operations, and biosurveillance as relevant to health security and emergency preparedness.

Country-Level Signals in Automated Molecular Diagnostics

Australia emphasizes quality assurance, regional access, and integration across dispersed healthcare networks. Brazil is influenced by public laboratory systems, infectious-disease surveillance, and geographic inequality. Canada prioritizes provincial coordination, laboratory quality, and access across remote communities. China is advancing domestic diagnostic capability alongside large and diverse healthcare demand. France, Germany, Italy, and Spain operate within European regulatory and quality frameworks while addressing procurement complexity and laboratory interoperability. India’s priorities include affordability, decentralization, and scalable testing capacity. Japan and South Korea emphasize precision, automation, and advanced hospital infrastructure. Mexico is balancing centralized public testing with broader regional access. Russia’s environment reflects domestic supply considerations and geographically distributed service needs. The United Kingdom focuses on diagnostic-network integration, validation, and health-system efficiency. The United States places strong emphasis on regulatory evidence, laboratory networks, reimbursement considerations, and rapid deployment during public-health events.

Strategic Recommendations for Industry Leaders

Leaders should design systems around measurable workflow outcomes: hands-on time, turnaround time, invalid-result rates, uptime, contamination control, and connectivity performance. Modular platforms can address differences in specimen volume and laboratory capability, while clear validation packages and transparent AI governance can support responsible adoption. Localization of service, training, consumables, and regulatory documentation is essential across heterogeneous markets. Organizations should also strengthen cybersecurity, maintain continuity plans for reagents and critical components, build interoperability from the outset, and collaborate with laboratories to demonstrate clinical utility rather than relying solely on technical specifications.

Research Methodology for the Executive Summary

This executive summary uses the supplied market definition-automated molecular diagnostics testing systems-and organizes qualitative insights across the specified regions, economic and political groups, and countries. The assessment considers technology architecture, laboratory workflow, clinical applications, regulation, infrastructure, procurement, workforce, interoperability, public-health preparedness, and responsible AI adoption. Claims are framed as evidence-based structural observations; no market estimates, market shares, forecasts, or company-specific assessments are included.

Conclusion: Building Reliable, Connected Molecular Testing Capacity

Automated molecular diagnostics testing systems are becoming central to laboratories seeking dependable, scalable, and less labor-intensive molecular workflows. Successful adoption will depend not only on analytical performance but also on integration, serviceability, affordability, regulatory readiness, data protection, and workforce capability. Industry leaders that align platform design with local health-system realities and apply AI under disciplined governance will be better positioned to support resilient diagnostic services across diverse regions and country settings.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Automated Molecular Diagnostics Testing System Market, by Product Type
7.1. Introduction
7.2. Consumables And Reagents
7.2.1. Amplification Reagents And Mastermixes
7.2.2. Cartridge Based Consumables
7.2.3. Extraction Reagents
7.2.4. Kits
7.3. Instruments And Systems
7.3.1. Benchtop And Portable Systems
7.3.2. Fully Integrated Platforms
7.3.3. Modular Instruments
7.3.4. Point Of Care Devices
7.4. Services And Support
7.4.1. Assay Development And Validation
7.4.2. Implementation And Training
7.4.3. Maintenance And Repair
7.5. Software And Informatics
7.5.1. Cloud Based Solutions And Hosting
7.5.2. Data Analysis Software
7.5.3. Laboratory Information System Integration
8. Automated Molecular Diagnostics Testing System Market, by Technology
8.1. Introduction
8.2. Hybridization And Signal Amplification
8.3. Isothermal Amplification
8.3.1. LAMP
8.3.2. NASBA
8.3.3. RPA
8.4. Mass Spectrometry Based Detection
8.5. Microarray
8.6. Next Generation Sequencing
8.6.1. Metagenomic Sequencing
8.6.2. Targeted Sequencing
8.6.3. Whole Genome Sequencing
8.7. Polymerase Chain Reaction
8.7.1. Digital PCR
8.7.2. Real Time PCR
8.7.3. Reverse Transcription PCR
9. Automated Molecular Diagnostics Testing System Market, by Application
9.1. Introduction
9.2. Genetic Testing
9.2.1. Carrier Screening
9.2.2. Inherited Disorders
9.2.3. Prenatal Screening
9.3. Infectious Diseases
9.3.1. Bloodborne Infections
9.3.2. Gastrointestinal Infections
9.3.3. Respiratory Infections
9.3.4. Sepsis
9.3.5. Sexually Transmitted Infections
9.4. Oncology
9.4.1. Liquid Biopsy
9.4.2. Minimal Residual Disease
9.4.3. Somatic Mutation Detection
9.5. Pharmacogenomics
9.6. Transplantation
9.6.1. Donor Matching
9.6.2. Rejection Monitoring
9.7. Veterinary Diagnostics
9.8. Women's Health
9.8.1. HPV Testing
9.8.2. Prenatal Diagnostics
10. Automated Molecular Diagnostics Testing System Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Commercial Laboratories
10.4. Hospitals And Clinics
10.5. Molecular Diagnostics Laboratories
10.6. Point Of Care Settings
10.7. Reference Laboratories
11. Automated Molecular Diagnostics Testing System Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Automated Molecular Diagnostics Testing System Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Automated Molecular Diagnostics Testing System Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Becton, Dickinson and Company
15.3. bioMérieux SA
15.4. Danaher Corporation
15.5. DiaSorin S.p.A.
15.6. F. Hoffmann-La Roche Ltd
15.7. Hologic, Inc.
15.8. PerkinElmer, Inc.
15.9. QIAGEN N.V.
15.10. Siemens Healthineers AG
15.11. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Automated Molecular Diagnostics Testing System Market, Years Considered for the Study
FIGURE 2. Global Automated Molecular Diagnostics Testing System Market, Research Design
FIGURE 3. Global Automated Molecular Diagnostics Testing System Market, Research Framework
FIGURE 4. Global Automated Molecular Diagnostics Testing System Market, Data Triangulation
FIGURE 5. Global Automated Molecular Diagnostics Testing System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Automated Molecular Diagnostics Testing System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Automated Molecular Diagnostics Testing System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Automated Molecular Diagnostics Testing System Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Automated Molecular Diagnostics Testing System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Automated Molecular Diagnostics Testing System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Automated Molecular Diagnostics Testing System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Automated Molecular Diagnostics Testing System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Automated Molecular Diagnostics Testing System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Automated Molecular Diagnostics Testing System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Automated Molecular Diagnostics Testing System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Automated Molecular Diagnostics Testing System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Automated Molecular Diagnostics Testing System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Automated Molecular Diagnostics Testing System Market Segmentation & Coverage
TABLE 2. Global Automated Molecular Diagnostics Testing System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Consumables And Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables And Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables And Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Amplification Reagents And Mastermixes Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Amplification Reagents And Mastermixes Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Amplification Reagents And Mastermixes Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cartridge Based Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cartridge Based Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cartridge Based Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Extraction Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Extraction Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Extraction Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Instruments And Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Instruments And Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Instruments And Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Benchtop And Portable Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Benchtop And Portable Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Benchtop And Portable Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Fully Integrated Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Fully Integrated Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Fully Integrated Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Modular Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Modular Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Modular Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Point Of Care Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Point Of Care Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Point Of Care Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Services And Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Services And Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Services And Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Assay Development And Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Assay Development And Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Assay Development And Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Implementation And Training Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Implementation And Training Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Implementation And Training Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Maintenance And Repair Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Maintenance And Repair Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Maintenance And Repair Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Software And Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Software And Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Software And Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Cloud Based Solutions And Hosting Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Cloud Based Solutions And Hosting Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Cloud Based Solutions And Hosting Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Laboratory Information System Integration Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Laboratory Information System Integration Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Laboratory Information System Integration Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 59. Global Hybridization And Signal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Hybridization And Signal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Hybridization And Signal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global LAMP Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global LAMP Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global LAMP Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global NASBA Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global NASBA Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global NASBA Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global RPA Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global RPA Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global RPA Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Mass Spectrometry Based Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Mass Spectrometry Based Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Mass Spectrometry Based Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Metagenomic Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Metagenomic Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Metagenomic Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Reverse Transcription PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Reverse Transcription PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Reverse Transcription PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Carrier Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Inherited Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Inherited Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Inherited Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Prenatal Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Prenatal Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Prenatal Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Bloodborne Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Bloodborne Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Bloodborne Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Gastrointestinal Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Gastrointestinal Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Gastrointestinal Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Sepsis Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Sepsis Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Sepsis Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Sexually Transmitted Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Sexually Transmitted Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Sexually Transmitted Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Liquid Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Minimal Residual Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Minimal Residual Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Minimal Residual Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Somatic Mutation Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Somatic Mutation Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Somatic Mutation Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Transplantation Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Transplantation Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Transplantation Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Donor Matching Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Donor Matching Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Donor Matching Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Rejection Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Rejection Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Rejection Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Veterinary Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Veterinary Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Veterinary Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Women's Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Women's Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Women's Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global HPV Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global HPV Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global HPV Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Prenatal Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Prenatal Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Prenatal Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Commercial Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Commercial Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Commercial Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Molecular Diagnostics Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Molecular Diagnostics Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Molecular Diagnostics Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Point Of Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Point Of Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Point Of Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Automated Molecular Diagnostics Testing System Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Transplantation, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by Women's Health, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. North America Automated Molecular Diagnostics Testing System Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. North America Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. North America Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 211. North America Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 212. North America Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 213. North America Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 214. North America Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 215. North America Automated Molecular Diagnostics Testing System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 216. North America Automated Molecular Diagnostics Testing System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 217. North America Automated Molecular Diagnostics Testing System Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 218. North America Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. North America Automated Molecular Diagnostics Testing System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 220. North America Automated Molecular Diagnostics Testing System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 221. North America Automated Molecular Diagnostics Testing System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 222. North America Automated Molecular Diagnostics Testing System Market Size, by Transplantation, 2017-2032 (USD Million)
TABLE 223. North America Automated Molecular Diagnostics Testing System Market Size, by Women's Health, 2017-2032 (USD Million)
TABLE 224. North America Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Latin America Automated Molecular Diagnostics Testing System Market Size, by Region, 2017-2032 (USD Million)
TABLE 226. Latin America Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. Latin America Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 228. Latin America Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 229. Latin America Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 230. Latin America Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 231. Latin America Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. Latin America Automated Molecular Diagnostics Testing System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 233. Latin America Automated Molecular Diagnostics Testing System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 234. Latin America Automated Molecular Diagnostics Testing System Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 235. Latin America Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Latin America Automated Molecular Diagnostics Testing System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 237. Latin America Automated Molecular Diagnostics Testing System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 238. Latin America Automated Molecular Diagnostics Testing System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 239. Latin America Automated Molecular Diagnostics Testing System Market Size, by Transplantation, 2017-2032 (USD Million)
TABLE 240. Latin America Automated Molecular Diagnostics Testing System Market Size, by Women's Health, 2017-2032 (USD Million)
TABLE 241. Latin America Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Europe Automated Molecular Diagnostics Testing System Market Size, by Region, 2017-2032 (USD Million)
TABLE 243. Europe Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. Europe Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 245. Europe Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 246. Europe Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 247. Europe Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 248. Europe Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. Europe Automated Molecular Diagnostics Testing System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 250. Europe Automated Molecular Diagnostics Testing System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 251. Europe Automated Molecular Diagnostics Testing System Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 252. Europe Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. Europe Automated Molecular Diagnostics Testing System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 254. Europe Automated Molecular Diagnostics Testing System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 255. Europe Automated Molecular Diagnostics Testing System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 256. Europe Automated Molecular Diagnostics Testing System Market Size, by Transplantation, 2017-2032 (USD Million)
TABLE 257. Europe Automated Molecular Diagnostics Testing System Market Size, by Women's Health, 2017-2032 (USD Million)
TABLE 258. Europe Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Middle East Automated Molecular Diagnostics Testing System Market Size, by Region, 2017-2032 (USD Million)
TABLE 260. Middle East Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. Middle East Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 262. Middle East Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 263. Middle East Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 264. Middle East Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 265. Middle East Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. Middle East Automated Molecular Diagnostics Testing System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 267. Middle East Automated Molecular Diagnostics Testing System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 268. Middle East Automated Molecular Diagnostics Testing System Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 269. Middle East Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Middle East Automated Molecular Diagnostics Testing System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 271. Middle East Automated Molecular Diagnostics Testing System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 272. Middle East Automated Molecular Diagnostics Testing System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 273. Middle East Automated Molecular Diagnostics Testing System Market Size, by Transplantation, 2017-2032 (USD Million)
TABLE 274. Middle East Automated Molecular Diagnostics Testing System Market Size, by Women's Health, 2017-2032 (USD Million)
TABLE 275. Middle East Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Africa Automated Molecular Diagnostics Testing System Market Size, by Region, 2017-2032 (USD Million)
TABLE 277. Africa Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Africa Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 279. Africa Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 280. Africa Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 281. Africa Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 282. Africa Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 283. Africa Automated Molecular Diagnostics Testing System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 284. Africa Automated Molecular Diagnostics Testing System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 285. Africa Automated Molecular Diagnostics Testing System Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 286. Africa Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Africa Automated Molecular Diagnostics Testing System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 288. Africa Automated Molecular Diagnostics Testing System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 289. Africa Automated Molecular Diagnostics Testing System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 290. Africa Automated Molecular Diagnostics Testing System Market Size, by Transplantation, 2017-2032 (USD Million)
TABLE 291. Africa Automated Molecular Diagnostics Testing System Market Size, by Women's Health, 2017-2032 (USD Million)
TABLE 292. Africa Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. Global Automated Molecular Diagnostics Testing System Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Group, 2017-2032 (USD Million)
TABLE 295. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 297. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 298. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 299. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 300. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 301. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 302. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 303. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 304. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 306. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 307. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 308. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Transplantation, 2017-2032 (USD Million)
TABLE 309. ASEAN Automated Molecular Diagnostics Testing System Market Size, by Women's Health, 2017-2032 (USD Million)
TABLE 310. ASEAN Automated Molecular Diagnostics Testing System Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. GCC Automated Molecular Diagnostics Testing System Market Size, by Group, 2017-2032 (USD Million)
TABLE 312. GCC Automated Molecular Diagnostics Testing System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 313. GCC Automated Molecular Diagnostics Testing System Market Size, by Consumables And Reagents, 2017-2032 (USD Million)
TABLE 314. GCC Automated Molecular Diagnostics Testing System Market Size, by Instruments And Systems, 2017-2032 (USD Million)
TABLE 315. GCC Automated Molecular Diagnostics Testing System Market Size, by Services And Support, 2017-2032 (USD Million)
TABLE 316. GCC Automated Molecular Diagnostics Testing System Market Size, by Software And Informatics, 2017-2032 (USD Million)
TABLE 31

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Fully Automatic Molecular Diagnostic System Market - Global Forecast 2026-2032 - Product Image

Fully Automatic Molecular Diagnostic System Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Nucleic Acid Amplification Testing Market - Global Forecast 2026-2032 - Product Image

Nucleic Acid Amplification Testing Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Molecular Methods Market - Global Forecast 2026-2032 - Product Image

Molecular Methods Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Point of Care Molecular Diagnostics Market - Global Forecast 2026-2032 - Product Image

Point of Care Molecular Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Nucleic Acid Testing Market - Global Forecast 2026-2032 - Product Image

Nucleic Acid Testing Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.